Modulating apoptosis as a target for effective therapy

Area of Science:

• Molecular Biology
• Pathogenesis
• Therapeutics

Background:

• Cell proliferation and death are critical in diseases like cancer, neurodegeneration, and autoimmune disorders.
• Understanding molecular regulation of these processes enables targeted therapies.
• Apoptosis (programmed cell death) is a key pathway for disease intervention.

Purpose of the Study:

• To review molecular targets and therapeutic strategies for diseases involving altered cell proliferation and death.
• To highlight advancements in targeting apoptosis for cancer, neurodegenerative, and autoimmune diseases.
• To explore the potential of gene therapy in neurodegenerative disorders.

Main Methods:

• Review of scientific literature on cell death and proliferation pathways.
• Analysis of molecular targets including TNF, caspases, p53-MDM2, NF-kappaB, PI3K, Bcl-2 family, IAPs, STAT, and Par-4.
• Examination of therapeutic approaches such as drug targeting, gene therapy, and immune modulation.

Main Results:

• Targeting apoptosis regulators (e.g., Bcl-2 family, IAPs) shows promise in cancer therapy.
• Interferon beta and STAT pathway modulation are used for autoimmune diseases.
• Blocking Par-4 and caspase activation can prevent neuronal death in neurodegenerative models.
• Gene therapy presents a potential treatment for neurodegenerative disorders.

Conclusions:

• Targeting cell death and proliferation pathways provides rational therapeutic strategies for various diseases.
• Diverse molecular targets and approaches, including apoptosis modulation and gene therapy, are being explored.
• Further research into these pathways can lead to more effective disease treatments.